BAYER AKTIENGESELLSCHAFT 29/08/2016 09:55 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Real-World Data from Multiple Countries Continue to Reaffirm Positive Benefit-Risk Profile of Bayer’s Xarelto® in Everyday Clinical Practice Número de registro: 242216